Le Lézard
Classified in: Health, Business
Subjects: ERN, CCA, FVT

Neovasc Announces Year End 2017 Financial Results Conference Call and Webcast


NASDAQ, TSX: NVCN

VANCOUVER, March 21, 2018 /PRNewswire/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, today announced that it will report financial results for the year ended December 31, 2017 and host a conference call and webcast at 4:30pm Eastern Time on Wednesday, March 28, 2018.

Conference Call & Webcast
Wednesday, March 28th @ 4:30pm Eastern Time

Domestic:                                

800-281-7973

International:                            

323-794-2093

Passcode:                               

4395026

Webcast:                                 

http://public.viavid.com/index.php?id=128910



Replays available through April 10:


Domestic:                                

844-512-2921

International:                            

412-317-6671

Conference ID:                         

4395026

 

About Neovasc Inc.
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducertm, for the treatment of refractory angina, which is not currently available in the United States and has been available in Europe since 2015, and the Tiaratm, for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada and Europe.  For more information, visit: www.neovasc.com.

SOURCE Neovasc Inc.


These press releases may also interest you

at 10:18
Richards Packaging Income Fund (the "Fund") announced today its cash distribution for the month ended April 30, 2024 of Cdn$0.11 per unit. This distribution will be to unitholders of record at the close of business on April 30, 2024 and will be...

at 10:15
Sterilization Equipment Market in terms of revenue was estimated to be worth $16.8 billion in 2024 and is poised to reach $24.7 billion by 2029, growing at a CAGR of 7.9% from 2024 to 2029 according to a new report by MarketsandMarketstm. The...

at 10:15
Stuart Therapeutics, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing therapies for the treatment of anterior segment, refractive and posterior segment eye disorders, today announced that the company will be...

at 10:13
Drink Harlo LLC, a groundbreaking wellness brand, announces the launch of its flagship product, Harlo?a unique 3-in-1 drink mix crafted to elevate hydration, energy levels, and recovery like never before. Drinkharlo.com is now live, offering...

at 10:00
Bernhard, one of America's largest privately-owned infrastructure firms, announced a groundbreaking 30-year Energy-as-a-Service (EaaS) partnership with Hackensack Meridian Health (HMH), New Jersey's largest health network....

at 10:00
Ziegler, a specialty investment bank, is pleased to announce its role as exclusive sell-side advisor to Retirement Housing Foundation (hereafter "RHF") on the sale of its 15-community senior living portfolio located across six states: California (7...



News published on and distributed by: